These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39150852)

  • 1. Lens-Sparing Perfluoro-Octane-Assisted External Drainage of Total Exudative Retinal Detachment in Coats' Disease.
    Sivalingam MD; Wakabayashi T; Kusaka S; Yonekawa Y
    Ophthalmic Surg Lasers Imaging Retina; 2024 Aug; 55(8):430-432. PubMed ID: 39150852
    [No Abstract]   [Full Text] [Related]  

  • 2. A Novel Approach to Subretinal Fluid Drainage in Coats'-Related Exudative Retinal Detachment.
    Blyden K; Levine DA; Craven C; Hubbard GB
    Ophthalmic Surg Lasers Imaging Retina; 2022 Jul; 53(7):407-409. PubMed ID: 35858234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Scleral Buckling, Transscleral Drainage of Subretinal Fluid, Intravitreal Anti-Vascular Endothelial Growth Factor, and Laser Photocoagulation in Stage 3B Coats' Total Retinal Detachment.
    Huang YC; Lai CC; Wu WC
    Ophthalmic Surg Lasers Imaging Retina; 2016 Sep; 47(9):865-8. PubMed ID: 27631484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of external subretinal fluid drainage on secondary glaucoma in Coats' disease.
    Han ES; Choung HK; Heo JW; Kim SJ; Yu YS
    J AAPOS; 2006 Apr; 10(2):155-8. PubMed ID: 16678751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhegmatogenous retinal detachment in Coats' disease: a case report.
    Khadka S; Byanju R; Parajuli S
    J Med Case Rep; 2021 Dec; 15(1):631. PubMed ID: 34969406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of an exudative retinal detachment associated with a giant retinal pigment epithelial tear.
    Desai UR; Kumar N
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):97-9. PubMed ID: 23410817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes of Total Exudative Retinal Detachments in Stage 3B Coats Disease.
    Li AS; Capone A; Trese MT; Sears JE; Kychenthal A; De la Huerta I; Ferrone PJ
    Ophthalmology; 2018 Jun; 125(6):887-893. PubMed ID: 29361355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coats' disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease.
    Yousef YA; ElRimawi AH; Nazzal RM; Qaroot AF; AlAref AH; Mohammad M; Abureesh O; Rejdak R; Nowomiejska K; Avitabile T; Toro MD; AlNawaiseh I
    Medicine (Baltimore); 2020 Apr; 99(16):e19623. PubMed ID: 32311932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of perfluorocarbon liquid in the surgical repair of a bullous retinal detachment secondary to Coats' disease.
    Devenyi RG
    Can J Ophthalmol; 1998 Dec; 33(7):385-6. PubMed ID: 9885755
    [No Abstract]   [Full Text] [Related]  

  • 10. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
    Ramasubramanian A; Shields CL
    Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant anti-VEGF therapy in Coats' disease].
    Fiorentzis M; Stavridis E; Seitz B; Viestenz A
    Ophthalmologe; 2015 May; 112(5):451-4. PubMed ID: 25134462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of short-term postoperative perfluoro-n-octane tamponade for pediatric complex retinal detachment.
    Imaizumi A; Kusaka S; Noguchi H; Shimomura Y; Sawaguchi S
    Am J Ophthalmol; 2014 Feb; 157(2):384-389.e2. PubMed ID: 24332376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and management of advanced Coats' disease.
    Silodor SW; Augsburger JJ; Shields JA; Tasman W
    Ophthalmic Surg; 1988 Feb; 19(2):89-93. PubMed ID: 3347463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective photocoagulation in Coats' disease: ten-year follow-up.
    Nucci P; Bandello F; Serafino M; Wilson ME
    Eur J Ophthalmol; 2002; 12(6):501-5. PubMed ID: 12510719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
    Li S; Deng G; Liu J; Ma Y; Lu H
    BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser treatment of Coats' disease.
    Couvillion SS; Margolis R; Mavrofjides E; Hess D; Murray TG
    J Pediatr Ophthalmol Strabismus; 2005; 42(6):367-8. PubMed ID: 16382562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total exudative retinal detachment in coats disease: biochemical analysis of the subretinal exudate.
    Hsu J; Forbes B; Maguire AM
    Retina; 2006 Sep; 26(7):831-3. PubMed ID: 16963863
    [No Abstract]   [Full Text] [Related]  

  • 18. EXTRAMACULAR FIBROSIS IN COATS' DISEASE.
    Daruich A; Matet A; Tran HV; Gaillard MC; Munier FL
    Retina; 2016 Oct; 36(10):2022-8. PubMed ID: 26991649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reemergence of dormant Coats disease after 30 years.
    Pérez-Campagne E; Wolfensberger TJ
    Eur J Ophthalmol; 2012; 22(3):509-12. PubMed ID: 21928259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sub-perfluoro-n-octane injection of ocular viscoelastic device assisted inverted internal limiting membrane flap for macular hole retinal detachment surgery: a novel technique.
    Lai CC; Wu AL; Chou HD; Teh WM; Chen KJ; Chen YP; Liu L; Hwang YS; Wu WC
    BMC Ophthalmol; 2020 Mar; 20(1):116. PubMed ID: 32199465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.